Tredje AP-fonden’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,496
| Closed | -$1.14M | – | 492 |
|
|
2024
Q1 | $1.14M | Hold |
9,496
| – | – | 0.01% | 456 |
|
|
2023
Q4 | $1.17M | Sell |
9,496
-1,095
| -10% | -$135K | 0.01% | 477 |
|
|
2023
Q3 | $1.37M | Sell |
10,591
-993
| -9% | -$129K | 0.02% | 437 |
|
|
2023
Q2 | $1.44M | Sell |
11,584
-1,768
| -13% | -$219K | 0.02% | 446 |
|
|
2023
Q1 | $1.95M | Buy |
13,352
+681
| +5% | +$99.7K | 0.03% | 391 |
|
|
2022
Q4 | $2.02M | Buy |
12,671
+373
| +3% | +$59.4K | 0.03% | 367 |
|
|
2022
Q3 | $1.64M | Buy |
+12,298
| New | +$1.64M | 0.03% | 381 |
|
|
2018
Q2 | – | Sell |
-9,980
| Closed | -$1.51M | – | 474 |
|
|
2018
Q1 | $1.51M | Buy |
9,980
+3,600
| +56% | +$544K | 0.05% | 352 |
|
|
2017
Q4 | $859K | Buy |
6,380
+3,240
| +103% | +$436K | 0.03% | 447 |
|
|
2017
Q3 | $459K | Sell |
3,140
-110
| -3% | -$16.1K | 0.02% | 508 |
|
|
2017
Q2 | $505K | Buy |
3,250
+860
| +36% | +$134K | 0.02% | 506 |
|
|
2017
Q1 | $347K | Sell |
2,390
-123
| -5% | -$17.9K | 0.01% | 517 |
|
|
2016
Q4 | $274K | Buy |
2,513
+893
| +55% | +$97.4K | 0.01% | 516 |
|
|
2016
Q3 | $197K | Buy |
1,620
+900
| +125% | +$109K | 0.01% | 536 |
|
|
2016
Q2 | $102K | Buy |
+720
| New | +$102K | ﹤0.01% | 536 |
|